Exchange: NASDAQ Sector: Healthcare Industry: Medical Care Facilities
Current Signal: BUY (auto-tracking)
-0.32% $92.16
America/New_York / 28 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 3 010.65 mill |
EPS: | -0.300 |
P/E: | -307.20 |
Earnings Date: | Apr 30, 2024 |
SharesOutstanding: | 32.67 mill |
Avg Daily Volume: | 0.297 mill |
RATING 2024-03-28 |
---|
S- |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Buy | |
Return On Asset: | Strong Buy | |
DE: | Buy | |
P/E: | Strong Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -307.20 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-10.83x |
Company: PE -307.20 | industry: PE 28.38 |
DISCOUNTED CASH FLOW VALUE |
---|
$103.26 (12.04%) $11.10 |
Date: 2024-03-28 |
Expected Trading Range (DAY) |
---|
$ 91.24 - 93.20 ( +/- 1.06%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-16 | Muscato Nick | Buy | 5 518 | Common Stock |
2024-02-20 | Muscato Nick | Sell | 327 | Common Stock |
2024-02-16 | Holton Adam Y | Buy | 5 518 | Common Stock |
2024-02-16 | Ginn Scott G | Buy | 16 553 | Common Stock |
2024-02-20 | Ginn Scott G | Sell | 3 218 | Common Stock |
INSIDER POWER |
---|
63.61 |
Last 95 transactions |
Buy: 494 149 | Sell: 102 098 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $92.16 (-0.32% ) |
Volume | 0.283 mill |
Avg. Vol. | 0.297 mill |
% of Avg. Vol | 95.01 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:34 | sell | $93.92 | N/A | Active |
---|
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.